Inhaled corticosteroids for stable chronic obstructive pulmonary disease

IA Yang, MS Clarke, EHA Sim… - Cochrane Database of …, 2012 - cochranelibrary.com
Background The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary
disease (COPD) has been the subject of much controversy. Major international guidelines …

Drug-induced anti-inflammatory response in A549 cells, as detected by Raman spectroscopy: a comparative analysis of the actions of dexamethasone and p-coumaric …

ECO da Silva, FM Dos Santos, ARB Ribeiro… - Analyst, 2019 - pubs.rsc.org
Corticosteroids are widely used as effective treatments for the control of chronic
inflammatory diseases. However, because their long-term administration carries serious …

Screening, prevention and treatment of osteoporosis in patients with chronic obstructive pulmonary disease–a population‐based database study

H Madsen, K Brixen, J Hallas - The Clinical Respiratory Journal, 2010 - Wiley Online Library
Introduction: A common extrapulmonary effect to chronic obstructive pulmonary disease
(COPD) is osteoporosis. Objectives: To characterise the diagnostic activity regarding …

Skeletal implications of chronic obstructive pulmonary disease

BM Misof, CA Moreira, K Klaushofer… - Current osteoporosis …, 2016 - Springer
Chronic obstructive pulmonary disease (COPD) is associated with numerous comorbidities,
among which osteoporosis is of high significance. Low bone mass and the occurrence of …

Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease

T Glaab, C Taube - Pulmonary Pharmacology & Therapeutics, 2011 - Elsevier
Chronic obstructive pulmonary disease (COPD) has been described as a heterogeneous
multifactorial disorder associated with an abnormal inflammatory response of the peripheral …

Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease

IA Yang, OR Ferry, MS Clarke… - Cochrane Database …, 2023 - cochranelibrary.com
Background The role of inhaled corticosteroids (ICS) in chronic obstructive pulmonary
disease (COPD) has been the subject of much uncertainty. COPD clinical guidelines …

[HTML][HTML] Roflumilast: the evidence for its clinical potential in the treatment of chronic obstructive pulmonary disease

LT Wagner, CA Kenreigh - Core Evidence, 2005 - ncbi.nlm.nih.gov
Aims: The purpose of this article is to review the clinical potential of roflumilast, a PDE4
inhibitor currently in phase III clinical trials, in the management of patients with COPD …

[图书][B] Signature Search Method Development and Application in Drug Discovery

Y Duan - 2022 - search.proquest.com
This dissertation is about the development of gene expression signature (GES) search
methods and their application in drug discovery, specifically for promoting healthy aging …

The pulmonary respiration, hematopoiesis, and erythrocytes

PS Timiras, M De Martinis - Physiological basis of aging and …, 2007 - taylorfrancis.com
This chapter is concerned with the external pulmonary respiration dealing with the input of
atmospheric air (rich in O2) and output of bodily air (rich in CO2)(Fig. 1), as well as the …

A retrospective study of cholinesterase inhibitors for Alzheimer's disease: the effect of cerebrovascular disease on patient outcomes and the impact of biases on the …

C Charbonneau - 2011 - papyrus.bib.umontreal.ca
Introduction: Dementia may be caused by Alzheimer's disease (AD), cerebrovascular
disease (CVD), or a combination of both. When CVD is associated with dementia, survival is …